MedPath
HSA Approval

PMS-SODIUM POLYSTYRENE SULFONATE SUSPENSION 15 g/60 ml

SIN06253P

PMS-SODIUM POLYSTYRENE SULFONATE SUSPENSION 15 g/60 ml

PMS-SODIUM POLYSTYRENE SULFONATE SUSPENSION 15 g/60 ml

June 20, 1991

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

V03AE01

polystyrene sulfonate

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Pendopharm

Halo Pharmaceutical Canada Inc.

Active Ingredients

SODIUM POLYSTYRENE SULPHONATE

15 g/60 ml

Tolevamer

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PMS-SODIUM POLYSTYRENE SULFONATE SUSPENSION 15 g/60 ml - HSA Approval | MedPath